insights_auto
Why is TNXP down 4.65%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
$7.70
arrow_downward
-4.65%(-0.37) 1D
$7.75
arrow_upward
+0.71% (+0.055)todayPre-market
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
$8.15
High
$8.33
Low
$7.69
Mkt. cap
145.71M
Avg. vol.
499.62K
Volume
543.00
52-wk high
$24.49
52-wk low
$7.69
EPS
-$12.92
Beta
1.78
Shares outstanding
17.15M
No. of employees
142
Open
$8.15
High
$8.33
Low
$7.69
Mkt. cap
145.71M
Avg. vol.
499.62K
Volume
543.00
52-wk high
$24.49
52-wk low
$7.69
EPS
-$12.92
Beta
1.78
Shares outstanding
17.15M
No. of employees
142
News stories
From web sources and news partners
MarketBeat
·
3 days ago
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Rating Raised to "Hold" at Wall Street Zen
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, United States
SectorBiotechnology
Websitetonixpharma.com